Ajer Jeffrey Robert 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Mar 7, 2024
Insider Transaction Report
Form 4
Ajer Jeffrey Robert
SVP, Chief Commercial Of
Transactions
- Sale
Common Stock
2024-03-05$87.07/sh−4,000$348,280→ 94,047 total
Footnotes (1)
- [F1]Trade made pursuant to a 10b5-1 plan executed on April 13, 2023.